– Bionano recently announced its fourth-quarter results, showing a huge 43% increase sales year-over-year in revenue to $4 million.
– Bionano had $38.4 million in cash and equivalents at the end of 2020, compared to $17.3 million the previous year.
Bionano Genomics Inc(BNGO) is a stock of interest due to the large impact the company has on the market. Here at Wall Street Facts we only cover the best stocks so make sure you check out our other articles. Today we will be diving deep into all of the essential information you need to know about BNGO. We will be studying the movement so you can make the best decision as an investor. The stock has moved upwards today by 3.70%. The high for today is 8.23 and today’s low is 7.86. This information is critical in deciding whether this investment is risky or not. We can see the stock is trending upwards, which means the volume of people buying this stock is greater than people selling it.
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.
As an investor, you can get an idea of where the stock is trending by the forecast. In this case, the high forecast for Bionano Genomics Inc is $15.00 and the low forecast is $14.00. We can get a look into the future by looking at past trends. Looking at Bionano Genomics Inc’s 5-year movement it seems it has grown 16.10%. Overall, Bionano Genomics Inc is in great shape going forward. They have a strong market cap of $2.26B and a very bright future ahead of them.